Table 6.
Comparison of clinical parameters analyzed and particular genotypes of the -197G > A IL-17 polymorphism in women with osteoporosis
| Parameter/genotype | GG | GA | AA |
|---|---|---|---|
| T-score | −2.93 ± 0.73 | −3.30 ± 0.67 | −2.97 ± 0.75 |
| Z-score | −1.50 ± 0.66 | −1.62 ± 0.50 | −1.40 ± 0.72 |
| Body mass (kg) | 64.11 ± 8.13 | 60.07 ± 9.22 | 59.68 ± 8.47 |
| Height (cm) | 163.61 ± 4.89 | 160.77 ± 4.90 | 157.82 ± 5.13 |
| Body mass index (kg/m2) | 25.92 ± 3.62 | 23.30 ± 4.11 | 22.61 ± 3.73 |
| Age | 60.07 ± 7.90 | 50.32 ± 8.18 | 52.13 ± 8.36 |
| Birth weight | 3192.68 ± 493.06 | 3062.23 ± 443.24 | 2878.24 ± 506.06 |
| Reproductive years | 37.28 ± 4.88 | 35.62 ± 5.39 | 34.02 ± 4.93 |
| Age of menarche | 13.68 ± 1.52 | 13.59 ± 1.84 | 12.87 ± 1.97 |
| Last menstrual period age* | 47.6 ± 4.82 | 50.78 ± 5.00 | 50.32 ± 4.36 |
| Number of pregnancies | 1.95 ± 1.09 | 1.93 ± 1.14 | 1.99 ± 1.31 |
| Years after menopause* | 10.31 ± 5.78 | 12.37 ± 6.33 | 12.85 ± 6.04 |
| BMD L2–L4 (g/cm2) | 0.84 ± 0.06 | 0.084 ± 0.04 | 0.082 ± 0.06 |
| BMD L2–L4 YA (%)* | 59.93 ± 6.02 | 76.32 ± 6.90 | 70.23 ± 6.93 |
| BMD L2–L4 AM (%)* | 69.73 ± 6.82 | 74.56 ± 6.14 | 80.88 ± 7.33 |
*P < 0.05 – significance of bold entries was observed by post hoc analysis.